GlassScriptPhysician profile
Matthew S Field
NPI 1922418375
$2,536.01
in general payments reported to CMS, 2019-2025
27 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $212 · 2021: $619 · 2022: $254 · 2023: $384 · 2024: $250 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067 · Travel and Lodging: $218 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.97 |
| Travel and Lodging | $217.58 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $428.55 | 2020-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Ethicon US, LLC | $362.69 | 2020-2025 | Echelon; Endopath, Vistaseal, Echelon Endopath |
| Abbvie INC. | $249.65 | 2021-2024 | |
| Intuitive Surgical, INC. | $236.95 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $181.17 | 2020-2025 | Gattex |
| Baxter Healthcare | $179.69 | 2019-2025 | Perclot |
| Csl Behring | $155.96 | 2020-2025 | Kcentra |
| Kerecis Limited | $105.31 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $66.65 | 2022-2025 | Matrixrib |
| Sirius Medical Systems | $63.94 | 2023 | Pintuition |
| Polynovo North America LLC | $51.52 | 2024-2025 | Novosorb Btm |
| Davol INC. | $49.29 | 2020-2021 | |
| Innocoll Pharmaceuticals Limited | $49.10 | 2021 | |
| Kls-Martin L.P. | $45.64 | 2022-2025 | |
| Allergan, INC. | $41.50 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $39.07 | 2021-2023 | V.A.C. Veraflo Cleanse Choice |
| W. L. Gore & Associates, INC. | $33.09 | 2024-2025 | Gore Synecor Biomaterial |
| Boston Scientific Corporation | $25.80 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $25.73 | 2025 | |
| Innovation Technologies INC | $23.16 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $21.90 | 2024 | Iovera, Exparel |
| Zimmer Biomet Holdings, INC. | $19.94 | 2021 | |
| Reprise Biomedical, INC. | $19.21 | 2025 | Miro3d |
| Merck Sharp & Dohme LLC | $18.35 | 2022 | |
| Pfizer INC. | $16.35 | 2022 | |
| Shire North American Group INC | $14.64 | 2019 | |
| Stryker Corporation | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.